Michael Mollerus
Lawyers
Filters
Allegro MicroSystems $420 million acquisition of Crocus Technology
We are advising Allegro MicroSystems on the acquisition
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction
Coty $750 million senior secured notes offering
The 6.625% notes are due 2030
Azul $800 million secured notes offering
The senior secured notes are due 2028
Azul $862 million exchange offers and consent solicitations
The exchange offer included the issuance of the senior secured notes due 2029 and 2030
GFL Environmental $650 million secondary offering
The subordinate voting shares are dual-listed on the NYSE and the Toronto Stock Exchange
Shearman & Sterling merger with Allen & Overy
We are advising Shearman & Sterling on the transaction
Oleoducto Central $100 million tender offer
The company purchased certain debt securities
Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Emerson $8.2 billion acquisition of National Instruments
We are advising Emerson on the transaction